

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.53617158 |
| 2 | negative T cell selection (GO:0043383) | 7.01980453 |
| 3 | regulation of regulatory T cell differentiation (GO:0045589) | 6.86450986 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.69071330 |
| 5 | negative regulation of cell killing (GO:0031342) | 6.69071330 |
| 6 | negative thymic T cell selection (GO:0045060) | 6.32688345 |
| 7 | positive T cell selection (GO:0043368) | 6.29035523 |
| 8 | positive thymic T cell selection (GO:0045059) | 6.05292294 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.01324332 |
| 10 | leukocyte aggregation (GO:0070486) | 5.89681430 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.85737055 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.75462306 |
| 13 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.52519059 |
| 14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.35365004 |
| 15 | T cell migration (GO:0072678) | 5.33783792 |
| 16 | thymic T cell selection (GO:0045061) | 5.32662782 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.31913458 |
| 18 | positive regulation of interleukin-17 production (GO:0032740) | 5.27211397 |
| 19 | regulation of T cell tolerance induction (GO:0002664) | 5.24748775 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.19355095 |
| 21 | T cell selection (GO:0045058) | 5.14617102 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 4.94234006 |
| 23 | positive regulation of tolerance induction (GO:0002645) | 4.84903574 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.84646160 |
| 25 | activated T cell proliferation (GO:0050798) | 4.78345932 |
| 26 | response to interleukin-15 (GO:0070672) | 4.73714891 |
| 27 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.72066907 |
| 28 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.69512394 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.65676764 |
| 30 | positive regulation of granulocyte differentiation (GO:0030854) | 4.51499153 |
| 31 | regulation of tolerance induction (GO:0002643) | 4.45221343 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.42075170 |
| 33 | signal complex assembly (GO:0007172) | 4.34460125 |
| 34 | tolerance induction (GO:0002507) | 4.28584927 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 4.20146452 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.19127795 |
| 37 | T cell receptor signaling pathway (GO:0050852) | 4.18498862 |
| 38 | negative regulation of T cell apoptotic process (GO:0070233) | 4.18218792 |
| 39 | regulation of B cell differentiation (GO:0045577) | 4.17945315 |
| 40 | negative regulation of stress fiber assembly (GO:0051497) | 4.16432473 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 4.15627415 |
| 42 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.12039884 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.11757445 |
| 44 | interferon-gamma production (GO:0032609) | 3.96428906 |
| 45 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.90107634 |
| 46 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.86251560 |
| 47 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.78116315 |
| 48 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.75987782 |
| 49 | positive regulation of interleukin-4 production (GO:0032753) | 3.75668282 |
| 50 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.71100988 |
| 51 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.71100988 |
| 52 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.70499434 |
| 53 | positive regulation of lamellipodium assembly (GO:0010592) | 3.60843023 |
| 54 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.57132392 |
| 55 | positive regulation of isotype switching (GO:0045830) | 3.52477441 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51803479 |
| 57 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.51159023 |
| 58 | type I interferon signaling pathway (GO:0060337) | 3.50356853 |
| 59 | cellular response to type I interferon (GO:0071357) | 3.50356853 |
| 60 | regulation of cell killing (GO:0031341) | 3.49858286 |
| 61 | positive regulation of cell killing (GO:0031343) | 3.48159526 |
| 62 | response to type I interferon (GO:0034340) | 3.46410070 |
| 63 | regulation of interleukin-17 production (GO:0032660) | 3.42019948 |
| 64 | positive regulation of DNA recombination (GO:0045911) | 3.39289447 |
| 65 | respiratory burst (GO:0045730) | 3.37500008 |
| 66 | natural killer cell differentiation (GO:0001779) | 3.33481220 |
| 67 | alpha-beta T cell differentiation (GO:0046632) | 3.32405055 |
| 68 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.27961309 |
| 69 | T cell differentiation (GO:0030217) | 3.27863340 |
| 70 | positive regulation of T cell mediated immunity (GO:0002711) | 3.25411397 |
| 71 | lymphocyte migration (GO:0072676) | 3.24153345 |
| 72 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.23778168 |
| 73 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23669684 |
| 74 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.23418893 |
| 75 | regulation of T cell mediated immunity (GO:0002709) | 3.23170609 |
| 76 | Peyers patch development (GO:0048541) | 3.23017417 |
| 77 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.23017417 |
| 78 | regulation of defense response to virus by virus (GO:0050690) | 3.22901982 |
| 79 | regulation of interleukin-4 production (GO:0032673) | 3.21635276 |
| 80 | positive regulation of macrophage differentiation (GO:0045651) | 3.19283413 |
| 81 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.17468313 |
| 82 | T cell homeostasis (GO:0043029) | 3.16734494 |
| 83 | negative regulation of leukocyte apoptotic process (GO:2000107) | 3.16456424 |
| 84 | immunoglobulin mediated immune response (GO:0016064) | 3.12455666 |
| 85 | neutrophil activation involved in immune response (GO:0002283) | 3.09728858 |
| 86 | T cell costimulation (GO:0031295) | 3.06791185 |
| 87 | regulation of granulocyte differentiation (GO:0030852) | 3.06446860 |
| 88 | alpha-beta T cell activation (GO:0046631) | 3.05830236 |
| 89 | regulation of T cell apoptotic process (GO:0070232) | 3.05663096 |
| 90 | regulation of alpha-beta T cell activation (GO:0046634) | 3.03841885 |
| 91 | lymphocyte costimulation (GO:0031294) | 3.02898360 |
| 92 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.02653370 |
| 93 | negative regulation of interleukin-12 production (GO:0032695) | 3.02542113 |
| 94 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.02223073 |
| 95 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.01389501 |
| 96 | regulation of isotype switching (GO:0045191) | 2.99557410 |
| 97 | positive regulation of interleukin-2 production (GO:0032743) | 2.99254595 |
| 98 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.97320665 |
| 99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.96988705 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 2.96988705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.62206773 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.88689364 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94968236 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.25832347 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.02877084 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.52905781 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.50206406 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.48550758 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.31777676 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.31236533 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.23218292 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.03520176 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.91331969 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.88473442 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.85154422 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.80643494 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.78503318 |
| 18 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.69092184 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.67470998 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61338363 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 2.44636591 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41874587 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.23300976 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17898801 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.14979652 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10536410 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 2.05475840 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.97829553 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.87301238 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84280651 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83445216 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83069883 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.81800647 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79368713 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71865135 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64672780 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62488238 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61046411 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56830957 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54695494 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50433370 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42770585 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42350248 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39404499 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39309749 |
| 46 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.37174731 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34178551 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31677711 |
| 49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30579095 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.30526732 |
| 51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28832181 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28825787 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27997364 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24999860 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19005752 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18308291 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16069317 |
| 58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15276233 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14409572 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14336812 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13730608 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11490211 |
| 63 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11297173 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10295643 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08960290 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07008810 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05785211 |
| 68 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04668557 |
| 69 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02582789 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01512473 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01505990 |
| 72 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99070748 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98758841 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98057492 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95574647 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95491684 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 0.91527535 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91396892 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91026569 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89733847 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89280834 |
| 82 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88243550 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85546725 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83524090 |
| 85 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83177129 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82904663 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82724140 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82507946 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81990190 |
| 90 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81218731 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81109522 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80980898 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79492175 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79168055 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77262944 |
| 96 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75301488 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.74673268 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74131007 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73460569 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73076829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.65625832 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.22915367 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.08715315 |
| 4 | MP0003436_decreased_susceptibility_to | 3.75079838 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 3.56077168 |
| 6 | MP0003724_increased_susceptibility_to | 3.52556823 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.21797603 |
| 8 | MP0001800_abnormal_humoral_immune | 3.08222260 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.84559404 |
| 10 | MP0000685_abnormal_immune_system | 2.81757993 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.75838372 |
| 12 | MP0001790_abnormal_immune_system | 2.73751164 |
| 13 | MP0005387_immune_system_phenotype | 2.73751164 |
| 14 | MP0009785_altered_susceptibility_to | 2.70572196 |
| 15 | MP0005025_abnormal_response_to | 2.69538979 |
| 16 | MP0001819_abnormal_immune_cell | 2.68947964 |
| 17 | MP0002723_abnormal_immune_serum | 2.66007672 |
| 18 | MP0003866_abnormal_defecation | 2.41377706 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.39895101 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.39649153 |
| 21 | MP0002405_respiratory_system_inflammati | 2.36652833 |
| 22 | MP0002398_abnormal_bone_marrow | 2.35794817 |
| 23 | MP0002419_abnormal_innate_immunity | 2.32450089 |
| 24 | MP0000703_abnormal_thymus_morphology | 2.21133962 |
| 25 | MP0000716_abnormal_immune_system | 2.20014101 |
| 26 | MP0001853_heart_inflammation | 2.18908306 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 2.11809883 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.11383126 |
| 29 | MP0001873_stomach_inflammation | 2.08270632 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.96461518 |
| 31 | MP0006082_CNS_inflammation | 1.95193562 |
| 32 | MP0002933_joint_inflammation | 1.91440300 |
| 33 | MP0001348_abnormal_lacrimal_gland | 1.90714600 |
| 34 | MP0002722_abnormal_immune_system | 1.89105018 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.88645932 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.85720642 |
| 37 | MP0004947_skin_inflammation | 1.78499225 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.77829967 |
| 39 | MP0002429_abnormal_blood_cell | 1.71520483 |
| 40 | MP0003787_abnormal_imprinting | 1.67815174 |
| 41 | MP0004381_abnormal_hair_follicle | 1.61927882 |
| 42 | MP0005310_abnormal_salivary_gland | 1.56734253 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.56284211 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.55344224 |
| 45 | MP0001661_extended_life_span | 1.47629549 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.43811785 |
| 47 | MP0000490_abnormal_crypts_of | 1.40036416 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.38488530 |
| 49 | MP0003303_peritoneal_inflammation | 1.32072070 |
| 50 | MP0002009_preneoplasia | 1.28459160 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.27765815 |
| 52 | MP0008469_abnormal_protein_level | 1.27703891 |
| 53 | MP0002006_tumorigenesis | 1.26721876 |
| 54 | MP0000604_amyloidosis | 1.23639014 |
| 55 | MP0009764_decreased_sensitivity_to | 1.10127001 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.02544490 |
| 57 | MP0004130_abnormal_muscle_cell | 1.01428889 |
| 58 | MP0005083_abnormal_biliary_tract | 0.97252127 |
| 59 | MP0002132_abnormal_respiratory_system | 0.90574279 |
| 60 | MP0009763_increased_sensitivity_to | 0.88457583 |
| 61 | MP0002693_abnormal_pancreas_physiology | 0.86469433 |
| 62 | MP0003448_altered_tumor_morphology | 0.85650714 |
| 63 | MP0001851_eye_inflammation | 0.84286985 |
| 64 | MP0008874_decreased_physiological_sensi | 0.83252446 |
| 65 | MP0001764_abnormal_homeostasis | 0.81765191 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.81456835 |
| 67 | MP0000858_altered_metastatic_potential | 0.81113698 |
| 68 | MP0004883_abnormal_blood_vessel | 0.81111627 |
| 69 | MP0001663_abnormal_digestive_system | 0.79263910 |
| 70 | MP0003828_pulmonary_edema | 0.78174481 |
| 71 | MP0003880_abnormal_central_pattern | 0.76880698 |
| 72 | MP0002396_abnormal_hematopoietic_system | 0.75000025 |
| 73 | MP0001765_abnormal_ion_homeostasis | 0.71760452 |
| 74 | MP0002127_abnormal_cardiovascular_syste | 0.69177431 |
| 75 | MP0002163_abnormal_gland_morphology | 0.68508419 |
| 76 | MP0003690_abnormal_glial_cell | 0.68501783 |
| 77 | MP0008004_abnormal_stomach_pH | 0.66274213 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.65188815 |
| 79 | MP0000249_abnormal_blood_vessel | 0.63406739 |
| 80 | MP0009278_abnormal_bone_marrow | 0.63078587 |
| 81 | MP0005390_skeleton_phenotype | 0.61928516 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.60189665 |
| 83 | MP0003123_paternal_imprinting | 0.59582351 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 0.58788907 |
| 85 | MP0008260_abnormal_autophagy | 0.56601717 |
| 86 | MP0005164_abnormal_response_to | 0.53951001 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.53543939 |
| 88 | MP0003878_abnormal_ear_physiology | 0.53543939 |
| 89 | MP0004134_abnormal_chest_morphology | 0.52392729 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.51961143 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.51925867 |
| 92 | MP0003252_abnormal_bile_duct | 0.51168984 |
| 93 | MP0003075_altered_response_to | 0.49726787 |
| 94 | MP0002928_abnormal_bile_duct | 0.47781484 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.43636171 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.43620615 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.41604532 |
| 98 | MP0001919_abnormal_reproductive_system | 0.41577896 |
| 99 | MP0003795_abnormal_bone_structure | 0.41402414 |
| 100 | MP0003045_fibrosis | 0.41152625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.92359686 |
| 2 | T lymphocytopenia (HP:0005403) | 6.19551670 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.00359549 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.84675461 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 5.61231106 |
| 6 | Stomatitis (HP:0010280) | 5.38693080 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 4.99693439 |
| 8 | Abnormality of T cells (HP:0002843) | 4.80548416 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.74217977 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.60555170 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.58949403 |
| 12 | Myositis (HP:0100614) | 4.53677002 |
| 13 | Autoimmune hemolytic anemia (HP:0001890) | 4.47473166 |
| 14 | Combined immunodeficiency (HP:0005387) | 4.44509009 |
| 15 | Recurrent abscess formation (HP:0002722) | 4.37924237 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 4.34925280 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 4.19598660 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.19598660 |
| 19 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.90594046 |
| 20 | Encephalitis (HP:0002383) | 3.86437589 |
| 21 | Orchitis (HP:0100796) | 3.82777810 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.80580512 |
| 23 | Optic neuritis (HP:0100653) | 3.76277386 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.76277386 |
| 25 | Pustule (HP:0200039) | 3.64594844 |
| 26 | Recurrent viral infections (HP:0004429) | 3.62431800 |
| 27 | Aplastic anemia (HP:0001915) | 3.60829795 |
| 28 | Recurrent skin infections (HP:0001581) | 3.56852445 |
| 29 | Lymphopenia (HP:0001888) | 3.56381007 |
| 30 | IgG deficiency (HP:0004315) | 3.55831569 |
| 31 | Abnormality of T cell physiology (HP:0011840) | 3.54893320 |
| 32 | Leukocytosis (HP:0001974) | 3.50101925 |
| 33 | Meningitis (HP:0001287) | 3.42286695 |
| 34 | Abnormality of eosinophils (HP:0001879) | 3.40295498 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.36732625 |
| 36 | Colitis (HP:0002583) | 3.31047303 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.24752125 |
| 38 | Increased IgM level (HP:0003496) | 3.21111000 |
| 39 | Eosinophilia (HP:0001880) | 3.15551985 |
| 40 | Agammaglobulinemia (HP:0004432) | 3.12220550 |
| 41 | Vasculitis (HP:0002633) | 3.10755058 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 3.09002772 |
| 43 | Thyroiditis (HP:0100646) | 3.08977912 |
| 44 | Granulocytopenia (HP:0001913) | 3.06151444 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 3.05862721 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.02081580 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.97704501 |
| 48 | Increased IgE level (HP:0003212) | 2.96986749 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.93570591 |
| 50 | Hypoplasia of the thymus (HP:0000778) | 2.89179498 |
| 51 | Obstructive lung disease (HP:0006536) | 2.88389636 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88389636 |
| 53 | Chest pain (HP:0100749) | 2.84515516 |
| 54 | Microcytic anemia (HP:0001935) | 2.83022983 |
| 55 | Hypochromic anemia (HP:0001931) | 2.81993841 |
| 56 | IgM deficiency (HP:0002850) | 2.81825868 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.76041141 |
| 58 | Hypergammaglobulinemia (HP:0010702) | 2.74045420 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.71837100 |
| 60 | Chronic diarrhea (HP:0002028) | 2.67102994 |
| 61 | Recurrent bronchitis (HP:0002837) | 2.60545384 |
| 62 | Keratoconjunctivitis (HP:0001096) | 2.56930226 |
| 63 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.51120296 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.50898288 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.46523901 |
| 66 | Anorexia (HP:0002039) | 2.34995112 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.34772129 |
| 68 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34731263 |
| 69 | Joint swelling (HP:0001386) | 2.33074769 |
| 70 | Hemoptysis (HP:0002105) | 2.32883564 |
| 71 | Hypoproteinemia (HP:0003075) | 2.29058616 |
| 72 | Gingival bleeding (HP:0000225) | 2.24627440 |
| 73 | Urticaria (HP:0001025) | 2.22944968 |
| 74 | Lymphoma (HP:0002665) | 2.22574391 |
| 75 | Gangrene (HP:0100758) | 2.09767873 |
| 76 | Epistaxis (HP:0000421) | 2.09678224 |
| 77 | Sepsis (HP:0100806) | 2.06898260 |
| 78 | Pulmonary embolism (HP:0002204) | 2.02893296 |
| 79 | Gonadal dysgenesis (HP:0000133) | 2.02594483 |
| 80 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.02078917 |
| 81 | Gingivitis (HP:0000230) | 2.00898684 |
| 82 | Episodic fever (HP:0001954) | 1.98875326 |
| 83 | B lymphocytopenia (HP:0010976) | 1.98277456 |
| 84 | Hyperlipoproteinemia (HP:0010980) | 1.92961391 |
| 85 | Abnormality of the fingertips (HP:0001211) | 1.92927632 |
| 86 | Petechiae (HP:0000967) | 1.92799974 |
| 87 | Arterial thrombosis (HP:0004420) | 1.92570334 |
| 88 | Abnormality of the pleura (HP:0002103) | 1.91983163 |
| 89 | Abnormality of B cell number (HP:0010975) | 1.89720527 |
| 90 | Viral hepatitis (HP:0006562) | 1.89402719 |
| 91 | Acute hepatic failure (HP:0006554) | 1.85993259 |
| 92 | Alveolar cell carcinoma (HP:0006519) | 1.83856510 |
| 93 | Papilloma (HP:0012740) | 1.79795551 |
| 94 | Verrucae (HP:0200043) | 1.79795551 |
| 95 | Papilledema (HP:0001085) | 1.77957738 |
| 96 | Constricted visual fields (HP:0001133) | 1.77693128 |
| 97 | Increased serum ferritin (HP:0003281) | 1.71528196 |
| 98 | Congenital stationary night blindness (HP:0007642) | 1.69939246 |
| 99 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.69580766 |
| 100 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.68607825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.61160562 |
| 2 | MAP4K1 | 4.47700810 |
| 3 | TNK2 | 3.46527203 |
| 4 | FES | 3.37820099 |
| 5 | KDR | 2.88637083 |
| 6 | PRPF4B | 2.84119553 |
| 7 | TESK2 | 2.82204011 |
| 8 | RIPK4 | 2.70254896 |
| 9 | CSK | 2.67633878 |
| 10 | BCKDK | 2.50244570 |
| 11 | ITK | 2.48752706 |
| 12 | ZAP70 | 2.44908836 |
| 13 | TEC | 2.27516636 |
| 14 | GRK6 | 2.13565392 |
| 15 | IRAK4 | 2.13269810 |
| 16 | BTK | 2.08992411 |
| 17 | SIK3 | 2.02281319 |
| 18 | TAOK3 | 1.94524746 |
| 19 | TYK2 | 1.88741528 |
| 20 | LCK | 1.80775576 |
| 21 | TAOK2 | 1.78682456 |
| 22 | SYK | 1.68750127 |
| 23 | HCK | 1.57093487 |
| 24 | JAK3 | 1.48330644 |
| 25 | PRKCQ | 1.48028035 |
| 26 | CDK19 | 1.46774020 |
| 27 | LYN | 1.40492142 |
| 28 | IKBKE | 1.39498242 |
| 29 | JAK1 | 1.39404476 |
| 30 | BLK | 1.35863145 |
| 31 | MAP3K11 | 1.31684098 |
| 32 | BMX | 1.20070985 |
| 33 | MELK | 1.16884147 |
| 34 | MARK3 | 1.15906606 |
| 35 | MAP2K3 | 1.13041048 |
| 36 | SIK2 | 1.12253221 |
| 37 | NLK | 1.11659922 |
| 38 | TESK1 | 1.09345042 |
| 39 | CSF1R | 1.08903942 |
| 40 | FGR | 1.07049949 |
| 41 | EPHB1 | 1.06266817 |
| 42 | TAOK1 | 1.01676220 |
| 43 | ADRBK2 | 1.01662096 |
| 44 | RPS6KA4 | 0.98105452 |
| 45 | MAP3K1 | 0.96055982 |
| 46 | MAP3K3 | 0.93865742 |
| 47 | ERN1 | 0.93551615 |
| 48 | PASK | 0.90991023 |
| 49 | JAK2 | 0.90250850 |
| 50 | LRRK2 | 0.89510911 |
| 51 | SCYL2 | 0.87468911 |
| 52 | GRK7 | 0.81862777 |
| 53 | TBK1 | 0.80697913 |
| 54 | STK10 | 0.73868651 |
| 55 | MAP3K14 | 0.70578503 |
| 56 | PIM1 | 0.69801843 |
| 57 | PINK1 | 0.67612436 |
| 58 | KSR2 | 0.67525448 |
| 59 | FYN | 0.66825918 |
| 60 | RAF1 | 0.66694375 |
| 61 | PTK6 | 0.66550674 |
| 62 | CAMKK2 | 0.63622262 |
| 63 | TYRO3 | 0.61192728 |
| 64 | SIK1 | 0.58646334 |
| 65 | IKBKB | 0.58041493 |
| 66 | PAK4 | 0.57953514 |
| 67 | CAMKK1 | 0.56910375 |
| 68 | CDC42BPA | 0.56520246 |
| 69 | MAP3K12 | 0.55367368 |
| 70 | TLK1 | 0.54983899 |
| 71 | MAPK11 | 0.52628103 |
| 72 | STK38 | 0.52379911 |
| 73 | PRKCH | 0.49160309 |
| 74 | FGFR3 | 0.47102797 |
| 75 | KIT | 0.44617357 |
| 76 | INSR | 0.42906690 |
| 77 | BRSK1 | 0.40121478 |
| 78 | SMG1 | 0.39943601 |
| 79 | MAPK12 | 0.39829040 |
| 80 | HIPK2 | 0.38489078 |
| 81 | PDK1 | 0.36484177 |
| 82 | ABL1 | 0.35969887 |
| 83 | MAPKAPK2 | 0.33378383 |
| 84 | FGFR4 | 0.30522370 |
| 85 | IRAK1 | 0.28746835 |
| 86 | RPS6KA5 | 0.28229512 |
| 87 | PDGFRB | 0.27248377 |
| 88 | VRK2 | 0.27230233 |
| 89 | PIK3CG | 0.27002485 |
| 90 | PTK2B | 0.26744563 |
| 91 | IRAK2 | 0.26642570 |
| 92 | EGFR | 0.24727582 |
| 93 | IGF1R | 0.23998867 |
| 94 | PRKD2 | 0.23505746 |
| 95 | MAP2K7 | 0.22128821 |
| 96 | TGFBR2 | 0.18914549 |
| 97 | PAK3 | 0.16880894 |
| 98 | YES1 | 0.15053204 |
| 99 | CDK4 | 0.14968990 |
| 100 | STK4 | 0.14786818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.88409340 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.89588012 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.52910392 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.33430616 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.28479756 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.21190780 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.68979906 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.57003222 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.50260575 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45279095 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16659121 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97278873 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.84924863 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.83093300 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75676989 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71904583 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71120677 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.70129279 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60758180 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51581500 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.50552338 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41824638 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36456277 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35792889 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34785286 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34548995 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31229214 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29324222 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.24058789 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.21461278 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.16666144 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12954077 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10715242 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08951425 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08373096 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03948392 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.01158873 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97228476 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93561962 |
| 40 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91542145 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90467761 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87318111 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 0.86387018 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85968104 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.85873994 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84786917 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83915956 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.83505664 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.79318897 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.78849938 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76578176 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76105396 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72944883 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72604868 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69152517 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.67829829 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67391535 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.64812812 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.63010085 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60052016 |
| 61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57884508 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55846979 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55258890 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54785296 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.51960813 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.51578337 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50777026 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.46579391 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43971177 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40191002 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40088518 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39425743 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38553259 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37949278 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37766197 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37664165 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36917305 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36691292 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36412032 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.35938537 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33946530 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31853801 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31026971 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.30618440 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30589774 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29879368 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29215186 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29097679 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24585493 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24233173 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23606635 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22616605 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21017510 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20638681 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.18857208 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.18590631 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18499865 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16583151 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.16174118 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15312709 |

